miR-96 regulates liver tumor-initiating cells expansion by targeting TP53INP1 and predicts Sorafenib resistance
Open Access
- 1 January 2020
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 11 (22) , 6545-6555
Abstract
Liver tumor-initiating cells (T-ICs) contribute to tumorigenesis, progression, recurrence and drug resistance of hepatocellular carcinoma (HCC). However, the underlying mechanism for the propagation of liver T-ICs remains unclear. In the present study, our finding shows that miR-96 is upregulated in liver T-ICs. Functional studies revealed that forced miR-96 promotes liver T-ICs self-renewal and tumorigenesis. Conversely, knockdown miR-96 inhibits liver T-ICs self-renewal and tumorigenesis. Mechanistically, miR-96 downregulates TP53INP1 via its mRNA 3'UTR in liver T-ICs. Furthermore, the miR-96 expression determines the responses of hepatoma cells to sorafenib treatment. Analysis of patient cohorts and patient-derived xenografts (PDXs) further demonstrate that the miR-96 may predict sorafenib benefits in HCC patients. Our findings revealed the crucial role of the miR-96 in liver T-ICs expansion and sorafenib response, rendering miR-96 as an optimal target for the prevention and intervention of HCC.Keywords
This publication has 32 references indexed in Scilit:
- Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapyAdvanced Drug Delivery Reviews, 2015
- Human and Mouse VEGFA-Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib TreatmentCancer Discovery, 2014
- Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cellsOncology Reports, 2012
- FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinomaHepatology, 2012
- Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cellsJournal of Hepatology, 2011
- miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1Cell Stem Cell, 2010
- Effects of Microrna-29 on Apoptosis, Tumorigenicity, and Prognosis of Hepatocellular CarcinomaHepatology, 2009
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell FeaturesGastroenterology, 2009
- Wnt/β-Catenin Signaling Contributes to Activation of Normal and Tumorigenic Liver Progenitor CellsCancer Research, 2008
- CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathwayOncogene, 2007